These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1804637)

  • 21. Calcium antagonists and myocardial protection.
    Kowalchuk GJ; Nesto RW
    Am J Cardiol; 1989 Sep; 64(11):10F-17F. PubMed ID: 2528906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial protection with verapamil during ischaemia and reperfusion: dissociation between myocardial salvage and the degree of ATP depletion during ischaemia.
    Wolfe CL; Donnelly TJ; Sievers R; Parmley WW
    Cardiovasc Res; 1991 Feb; 25(2):101-9. PubMed ID: 1742760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
    Gülker H; Haverkamp W; Hindricks G; Bender F
    Cardiovasc Drugs Ther; 1987 Dec; 1(4):367-76. PubMed ID: 3154673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the cardioprotective effects of calcium antagonists from different classes upon ischaemic damage in the guinea-pig working heart.
    Hugtenburg JG; Mathy MJ; Veldsema-Currie RD; Boddeke HW; Beckeringh JJ; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):126-34. PubMed ID: 2797212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonist.
    Hohlfeld T; Braun M; Strobach H; Schrör K
    J Cardiovasc Pharmacol; 1994 Jun; 23(6):922-31. PubMed ID: 7523784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic management of ischemic heart disease with beta-blockers and calcium channel blockers.
    Pearle DL
    Am Heart J; 1990 Sep; 120(3):739-42; discussion 743-5. PubMed ID: 1975155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lacidipine on ischaemic and reperfused isolated rabbit hearts.
    Boraso A; Cargnoni A; Comini L; Gaia G; Bernocchi P; Ferrari R
    Mol Cell Biochem; 1993 Aug; 125(1):73-86. PubMed ID: 8264575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of myocardial protective action of dilazep during ischaemia and reperfusion.
    Cargnoni A; Condorelli E; Ceconi C; Curello S; Albertini A; Ferrari R
    Pharmacol Res Commun; 1987 May; 19(5):341-57. PubMed ID: 3628458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):461-91. PubMed ID: 3154677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium antagonists and stunned myocardium: importance for clinicians?
    Przyklenk K; Kloner RA
    Cardiovasc Drugs Ther; 1991 Oct; 5(5):947-51. PubMed ID: 1756142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo.
    García-Rivas Gde J; Carvajal K; Correa F; Zazueta C
    Br J Pharmacol; 2006 Dec; 149(7):829-37. PubMed ID: 17031386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms involved in reperfusion arrhythmias.
    Verrier RL; Hagestad EL
    Eur Heart J; 1986 May; 7 Suppl A():13-22. PubMed ID: 3522236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why Ca2+ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established.
    Hugenholtz PG; Serruys PW; Fleckenstein A; Nayler W
    Eur Heart J; 1986 Apr; 7(4):270-8. PubMed ID: 2873037
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-apoptotic effect of benidipine, a long-lasting vasodilating calcium antagonist, in ischaemic/reperfused myocardial cells.
    Gao F; Gong B; Christopher TA; Lopez BL; Karasawa A; Ma XL
    Br J Pharmacol; 2001 Feb; 132(4):869-78. PubMed ID: 11181428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms of the protective action of the calcium antagonists corynphar and verapamil in myocardial ischemia and subsequent reperfusion].
    Litvitskiĭ PF
    Farmakol Toksikol; 1982; 45(2):65-70. PubMed ID: 7075755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological introduction to the clinical use of calcium antagonists].
    Ferrari R; Boraso A; De Giuli F; Cargnoni A; Pasini E; Condorelli E; Boffa GM; Visioli O
    G Ital Cardiol; 1988 Nov; 18(11):956-69. PubMed ID: 2854799
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction between calcium channel blockers and volatile anaesthetics in the rat heart-lung preparation.
    Kashimoto S; Oguchi T; Kume M; Kumazama T
    Br J Anaesth; 1990 May; 64(5):601-5. PubMed ID: 2354099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium antagonists and the ischemic myocardium.
    Nayler WG
    Int J Cardiol; 1987 Jun; 15(3):267-85. PubMed ID: 3298079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium antagonists and myocardial microperfusion.
    Tillmanns H; Neumann FJ; Parekh N; Waas W; Möller P; Zimmermann R; Steinhausen M; Köbler W
    Drugs; 1991; 42 Suppl 1():1-6. PubMed ID: 1718689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of calcium channel antagonist therapy on the ischemic response to acute coronary occlusion in humans.
    Kern MJ
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III77-85. PubMed ID: 2691144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.